Literature DB >> 4180276

Fixation of the first component of complement (C'la) by human antibodies.

W F Rosse.   

Abstract

The fixation of the first component of complement (C'1a) by human antibodies and human cells has been studied by the use of the C'1a fixation and transfer test (C'1a FT test) of Borsos and Rapp.Cold agglutinin antibodies appear to require no more than one antibody molecule to fix one molecule of C'1a. Most warm agglutinin antibodies are IgG in immunoglobulin type and require at least two molecules of antibody to fix a molecule of C'1a. Donath-Landsteiner antibody has the same requirements for C'1a fixation. A single example of a warm agglutinin antibody which appears to require one molecule of antibody for the fixation of C'1a was found. Antibodies of the Rh system do not fix significant amounts of C'1a in the absence of anti-antibody when antiserum of a single Rh specificity was used. However, when three antisera at different specificity are present, C'1a may be fixed. Under these conditions cells from a patient with paroxysmal nocturnal hemoglobinuria may be lysed when fresh serum is added to provide the other components of complement. The presence of IgG antibodies could be detected by the use of anti-IgG(Hu) antiserum and a one-to-one relationship between the concentration of antiserum in the reaction and the amount of C'1a fixed could be established. The effect of temperature, ionic strength, papainization of the red cells, and repeated washing of the red cell-antibody aggregates on the amount of C'1a fixed was investigated. Conditions of maximal C'1a fixation were established for each class of antibodies. Globulins present in normal isologous or autologous serum are absorbed in small amounts to normal red cells in a manner analogous to warm agglutinin antibody. Their presence is detectable by the C'1a fixation and transfer test only with antiglobulin antiserum. Within certain limits, the C'1a fixation and transfer test provides a quantitative measure of the reaction of human red cells and antibodies to antigens on their surface.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4180276      PMCID: PMC297409          DOI: 10.1172/JCI105926

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Life span of red blood cell.

Authors:  N I BERLIN; T A WALDMANN; S M WEISSMAN
Journal:  Physiol Rev       Date:  1959-07       Impact factor: 37.312

2.  STUDIES ON THE TERMINAL STEPS OF IMMUNE HEMOLYSIS. I. INHIBITION BY TRISODIUM ETHYLENEDIAMINETETRAACETATE (EDTA).

Authors:  M M FRANK; H J RAPP; T BORSOS
Journal:  J Immunol       Date:  1964-09       Impact factor: 5.422

3.  CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.

Authors:  T BORSOS; H J RAPP
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

4.  EFFECTS OF LOW IONIC STRENGTH ON IMMUNE HEMOLYSIS.

Authors:  H J RAPP; T BORSOS
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

5.  SEROLOGY OF ACQUIRED HEMOLYTIC ANEMIAS.

Authors:  W WEINER; G H VOS
Journal:  Blood       Date:  1963-11       Impact factor: 22.113

6.  THE EFFECT OF FICIN ON THE REACTION BETWEEN ANTI-D AND RED CELLS.

Authors:  N C HUGHES-JONES; B GARDNER; R TELFORD
Journal:  Vox Sang       Date:  1964 Mar-Apr       Impact factor: 2.144

7.  ESTIMATION OF MOLECULAR SIZE OF COMPLEMENT COMPONENTS BY SEPHADEX CHROMATOGRAPHY.

Authors:  T BORSOS; H J RAPP
Journal:  J Immunol       Date:  1965-04       Impact factor: 5.422

8.  CHARACTERIZATION OF A HUMAN MACROGLOBULIN. I. THE MOLECULAR WEIGHT OF ITS SUBUNIT.

Authors:  F MILLER; H METZGER
Journal:  J Biol Chem       Date:  1965-08       Impact factor: 5.157

9.  The I antigen and antibody.

Authors:  W J JENKINS; W L MARSH; J NOADES; P TIPPETT; R SANGER; R R RACE
Journal:  Vox Sang       Date:  1960-02       Impact factor: 2.144

10.  Complement fixation on cell surfaces by 19S and 7S antibodies.

Authors:  T Borsos; H J Rapp
Journal:  Science       Date:  1965-10-22       Impact factor: 47.728

View more
  11 in total

1.  Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked.

Authors:  Michael Huber; Viktor von Wyl; Christoph G Ammann; Herbert Kuster; Gabriela Stiegler; Hermann Katinger; Rainer Weber; Marek Fischer; Heribert Stoiber; Huldrych F Günthard; Alexandra Trkola
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

2.  Pathogenesis of hemolysis in immune hemolytic anemia.

Authors:  J R Cohen
Journal:  West J Med       Date:  1977-10

Review 3.  Tissue-specific autoantibodies in haemolytic anaemia.

Authors:  S Worlledge
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

4.  Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.

Authors:  W F Rosse; G L Logue; J Adams; J H Crookston
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

5.  Activation of mouse complement by different classes of mouse antibody.

Authors:  G G Klaus; M B Pepys; K Kitajima; B A Askonas
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

6.  Quantitative immunology of immune hemolytic anemia. I. The fixation of C1 by autoimmune antibody and heterologous anti-IgG antibody.

Authors:  W F Rosse
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

7.  Quantitative immunology of immune hemolytic anemia: II. The relationship of cell-bound antibody to hemolysis and the effect of treatment.

Authors:  W F Rosse
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

8.  The significance of erythrocyte antigen site density. II. Hemolysis.

Authors:  L W Hoyer; N C Trabold
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

9.  The detection of cell-bound antibody on complement-coated human red cells.

Authors:  B C Gilliland; J P Leddy; J H Vaughan
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

10.  Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome.

Authors:  G L Logue; W F Rosse; J P Gockerman
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.